Astera Labs (NASDAQ:ALAB) General Counsel Sells $2,315,740.50 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 6,801 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

• On Thursday, May 21st, Philip Mazzara sold 796 shares of Astera Labs stock. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88.

Astera Labs Trading Down 1.9%

ALAB stock opened at $284.97 on Friday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market capitalization of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84. The firm’s 50-day moving average is $352.70 and its two-hundred day moving average is $244.92.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada boosted its holdings in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares in the last quarter. AQR Capital Management LLC grew its position in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its position in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. UBS Group reissued a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective for the company in a report on Monday, August 17th. Finally, Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.